This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Former medical device executive's US bribery trial rescheduled to May 2027

( March 26, 2026, 15:39 GMT | Official Statement) -- MLex Summary: At the joint request of the prosecution and the defense, a US judge rescheduled the corruption trial of former medical device company executive David Ferrera to May 2027. At his arraignment, the judge initially scheduled the trial for May 2026, the joint request noted, but the defense said it needs more time to prepare for trial.Documents attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login